PaxMedica Files 8-K: Corporate Updates & Financials
| Field | Detail |
|---|---|
| Company | Paxmedica, Inc. |
| Form Type | 8-K |
| Filed Date | Jun 13, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-update, filing, financials
TL;DR
PaxMedica (fka Kuvatris) filed an 8-K for corporate changes and financials. Keep an eye on this.
AI Summary
PaxMedica, Inc. (formerly Kuvatris Therapeutics, Inc.) filed an 8-K on June 13, 2025, reporting events as of June 6, 2025. The filing indicates amendments to its Articles of Incorporation or Bylaws, other events, and financial statements/exhibits. The company's principal executive offices are located in Mahwah, NJ, with a mailing address in Boston, MA.
Why It Matters
This 8-K filing signals potential corporate restructuring or significant operational updates for PaxMedica, Inc., which could impact its business strategy and investor outlook.
Risk Assessment
Risk Level: medium — 8-K filings often contain material information that can lead to stock price volatility, especially when related to corporate structure or financial reporting.
Key Players & Entities
- PaxMedica, Inc. (company) — Registrant
- Kuvatris Therapeutics, Inc. (company) — Former name of registrant
- June 6, 2025 (date) — Earliest event reported date
- June 13, 2025 (date) — Filing date
- Delaware (jurisdiction) — State of incorporation
- 001-41475 (identifier) — Commission File Number
- 1000 Wyckoff Avenue, 3rd Floor, Mahwah, NJ 07430 (address) — Principal executive offices
- 101 Arch Street, 8th Floor, Boston, MA 02110 (address) — Mailing address
FAQ
What specific amendments were made to PaxMedica, Inc.'s Articles of Incorporation or Bylaws?
The filing indicates 'Amendments to Articles of Incorporation or Bylaws' as an item, but the specific details of these amendments are not provided in the excerpt.
What are the 'Other Events' reported by PaxMedica, Inc. on June 6, 2025?
The filing lists 'Other Events' as a reported item, but the nature of these events is not detailed in the provided text.
What financial statements and exhibits are included with this 8-K filing?
The filing mentions 'Financial Statements and Exhibits' as an item, but the specific content of these statements and exhibits is not detailed in the excerpt.
When did PaxMedica, Inc. officially change its name from Kuvatris Therapeutics, Inc.?
The filing lists 'Kuvatris Therapeutics, Inc.' as the former name of the registrant, PaxMedica, Inc., but does not specify the exact date of the name change.
What is the primary business of PaxMedica, Inc. according to its SIC code?
PaxMedica, Inc. is classified under Standard Industrial Classification code 2834, which corresponds to 'PHARMACEUTICAL PREPARATIONS'.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 13, 2025 regarding PaxMedica, Inc..